Title | Type | SJR | H index | Total Docs. (2017) | Total Docs. (3years) | Total Refs. (2017) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2017) | %Female (2017) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100 | Gaceta Mexicana de Oncologia | journal | 0.106 Q4 | 7 | 64 | 195 | 2095 | 11 | 173 | 0.09 | 32.73 | 37.66 | |
99 | Pathogenesis | journal | 0.129 Q4 | 8 | 0 | 10 | 0 | 7 | 9 | 0.78 | 0.00 | 0.00 | |
98 | Cancer Metastasis - Biology and Treatment | book series | 0.133 Q4 | 6 | 0 | 38 | 0 | 5 | 37 | 0.36 | 0.00 | 0.00 | |
97 | Open Cancer Journal | journal | 0.160 Q4 | 7 | 0 | 6 | 0 | 3 | 6 | 0.60 | 0.00 | 0.00 | |
96 | Open Breast Cancer Journal | journal | 0.171 Q4 | 5 | 0 | 2 | 0 | 1 | 2 | 0.00 | 0.00 | 0.00 | |
95 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.211 Q4 | 50 | 6 | 29 | 2272 | 29 | 22 | 0.70 | 378.67 | 0.00 | |
94 | Bulletin du Cancer | journal | 0.219 Q4 | 44 | 176 | 533 | 5357 | 340 | 448 | 0.72 | 30.44 | 51.63 | |
93 | Clinical Cancer Drugs | journal | 0.242 Q4 | 4 | 0 | 6 | 0 | 8 | 6 | 1.33 | 0.00 | 0.00 | |
92 | Cancer Treatment and Research Communications | journal | 0.250 Q4 | 23 | 29 | 117 | 1022 | 54 | 117 | 0.43 | 35.24 | 32.56 | |
91 | Breast Disease | journal | 0.276 Q4 | 36 | 18 | 84 | 325 | 70 | 83 | 0.79 | 18.06 | 36.36 | |
90 | South Asian Journal of Cancer | journal | 0.373 Q4 | 25 | 78 | 219 | 966 | 168 | 128 | 0.63 | 12.38 | 33.17 | |
89 | Tumori | journal | 0.396 Q4 | 59 | 121 | 494 | 3801 | 497 | 475 | 1.05 | 31.41 | 40.60 | |
88 | International Journal of Cancer Management | journal | 0.402 Q4 | 26 | 158 | 189 | 4600 | 221 | 170 | 1.25 | 29.11 | 42.67 | |
87 | Journal of Biological Regulators and Homeostatic Agents | journal | 0.407 Q4 | 56 | 269 | 537 | 5389 | 1097 | 499 | 2.06 | 20.03 | 41.22 | |
86 | In Vivo | journal | 0.409 | 72 | 178 | 410 | 5247 | 528 | 410 | 1.24 | 29.48 | 29.85 | |
85 | Journal of B.U.ON. | journal | 0.420 Q4 | 37 | 274 | 687 | 7242 | 838 | 602 | 1.35 | 26.43 | 37.57 | |
84 | Experimental and Therapeutic Medicine (discontinued) | journal | 0.510 Q3 | 63 | 1419 | 2451 | 46444 | 3841 | 2449 | 1.55 | 32.73 | 40.74 | |
83 | Oncology Research and Treatment | journal | 0.515 Q3 | 55 | 158 | 363 | 3632 | 438 | 309 | 1.01 | 22.99 | 34.33 | |
82 | International Journal of Biological Markers | journal | 0.545 Q3 | 47 | 75 | 157 | 2398 | 217 | 154 | 1.52 | 31.97 | 45.31 | |
81 | Oncology Letters | journal | 0.599 Q3 | 81 | 1837 | 3669 | 64295 | 6396 | 3664 | 1.75 | 35.00 | 37.05 | |
80 | Hematological Oncology | journal | 0.605 Q3 | 54 | 150 | 133 | 4187 | 216 | 113 | 1.74 | 27.91 | 43.91 | |
79 | Progress in Tumor Research | book series | 0.682 Q3 | 12 | 0 | 31 | 0 | 43 | 30 | 1.57 | 0.00 | 0.00 | |
78 | ecancermedicalscience | journal | 0.688 Q3 | 47 | 84 | 332 | 3097 | 560 | 332 | 1.79 | 36.87 | 37.67 | |
77 | Molecular Medicine Reports | journal | 0.691 Q3 | 86 | 1825 | 4086 | 65968 | 8365 | 4086 | 2.03 | 36.15 | 40.63 | |
76 | Anticancer Research | journal | 0.717 Q3 | 136 | 905 | 2716 | 28592 | 5507 | 2712 | 1.96 | 31.59 | 30.28 | |
75 | Human Cell | journal | 0.748 Q3 | 44 | 32 | 69 | 1181 | 144 | 65 | 1.93 | 36.91 | 35.26 | |
74 | Pathology and Oncology Research | journal | 0.751 Q3 | 61 | 117 | 411 | 3954 | 775 | 386 | 1.86 | 33.79 | 39.68 | |
73 | Future Oncology | journal | 0.759 Q3 | 90 | 312 | 951 | 12756 | 1848 | 844 | 1.84 | 40.88 | 38.29 | |
72 | Journal of Oral Pathology and Medicine | journal | 0.791 Q3 | 95 | 163 | 354 | 4675 | 812 | 345 | 2.28 | 28.68 | 45.36 | |
71 | Cancer Genomics and Proteomics | journal | 0.818 Q3 | 50 | 46 | 114 | 2614 | 292 | 114 | 2.55 | 56.83 | 41.03 | |
70 | Clinical and Translational Oncology | journal | 0.819 Q3 | 61 | 180 | 440 | 6370 | 1042 | 426 | 2.43 | 35.39 | 41.18 | |
69 | Cancer Biomarkers | journal | 0.826 Q3 | 54 | 221 | 273 | 7335 | 661 | 269 | 2.55 | 33.19 | 40.39 | |
68 | Experimental Hematology and Oncology | journal | 0.842 Q3 | 42 | 32 | 93 | 1249 | 247 | 90 | 2.98 | 39.03 | 41.75 | |
67 | Infectious Agents and Cancer | journal | 0.855 Q3 | 47 | 56 | 148 | 2651 | 364 | 147 | 2.55 | 47.34 | 45.78 | |
66 | Cancer Journal | journal | 0.861 Q3 | 16 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
65 | Oncology Reviews | journal | 0.926 Q3 | 31 | 10 | 28 | 763 | 86 | 28 | 2.67 | 76.30 | 31.58 | |
64 | International Journal of Hyperthermia | journal | 0.941 Q3 | 98 | 127 | 279 | 5043 | 922 | 268 | 3.24 | 39.71 | 29.71 | |
63 | Japanese Journal of Clinical Oncology | journal | 0.942 Q3 | 95 | 196 | 622 | 4666 | 1345 | 567 | 2.24 | 23.81 | 17.21 | |
62 | Familial Cancer | journal | 0.963 Q3 | 67 | 81 | 241 | 2175 | 528 | 237 | 2.12 | 26.85 | 56.11 | |
61 | Cancer Treatment and Research | journal | 0.974 Q3 | 65 | 12 | 184 | 924 | 543 | 135 | 2.84 | 77.00 | 0.00 | |
60 | Leukemia and Lymphoma | journal | 0.976 Q3 | 102 | 453 | 1633 | 12825 | 2588 | 1000 | 1.53 | 28.31 | 43.60 | |
59 | Oncology Reports | journal | 1.011 Q3 | 115 | 804 | 2316 | 31727 | 7058 | 2316 | 2.98 | 39.46 | 37.84 | |
58 | Oncology | journal | 1.013 Q3 | 107 | 129 | 315 | 3851 | 748 | 305 | 2.26 | 29.85 | 26.97 | |
57 | Leukemia Research | journal | 1.063 Q2 | 96 | 185 | 645 | 6493 | 1459 | 591 | 2.23 | 35.10 | 45.29 | |
56 | Cancer Cell International | journal | 1.130 Q2 | 80 | 117 | 340 | 5101 | 1198 | 340 | 3.95 | 43.60 | 40.98 | |
55 | Cancer Chemotherapy and Pharmacology | journal | 1.147 Q2 | 122 | 260 | 841 | 8494 | 2576 | 824 | 2.94 | 32.67 | 31.44 | |
54 | Virus Research | journal | 1.147 Q2 | 144 | 288 | 841 | 16160 | 2253 | 829 | 2.48 | 56.11 | 39.57 | |
53 | Journal of Neuro-Oncology | journal | 1.168 Q2 | 135 | 336 | 969 | 10890 | 3013 | 905 | 3.02 | 32.41 | 36.20 | |
52 | International Journal of Oncology | journal | 1.169 Q2 | 139 | 401 | 1543 | 17915 | 5390 | 1543 | 3.45 | 44.68 | 37.09 | |
51 | Molecular Therapy - Oncolytics | journal | 1.193 Q2 | 42 | 34 | 66 | 1695 | 241 | 64 | 3.87 | 49.85 | 39.01 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®